SEC Company Response from KALA BIO, Inc. (KALA) (CIK 0001479419) (KALA) — Jul 17, 2017
KALA BIO, Inc. (KALA) (CIK 0001479419)
Date: July 17, 2017 · CIK: 0001479419 · Accession: 0001104659-17-045293
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-218936
Letter
Kala Pharmaceuticals, Inc.
100 Beaver Street, Suite 201
Waltham, MA 02453
July 17, 2017
VIA EDGAR
Securities and Exchange Commission
Division of Corporation Finance
100 F Street, NE
Washington, DC 20549
Re: Kala Pharmaceuticals, Inc.
Registration Statement on Form S-1
File No. 333-218936
Request for Acceleration
Ladies and Gentlemen:
Pursuant to Rule 461 promulgated under the Securities Act of 1933, as amended, Kala Pharmaceuticals, Inc. (the “Registrant”) hereby requests acceleration of the effective date of its Registration Statement on Form S-1 (File No. 333-218936), as amended (the “Registration Statement”), so that it may become effective at 4:00 p.m. Eastern time on July 19, 2017, or as soon thereafter as practicable.
[The remainder of this page is intentionally left blank.]
Very truly yours,
Kala Pharmaceuticals, Inc.
Show Raw Text
CORRESP 1 filename1.htm Kala Pharmaceuticals, Inc. 100 Beaver Street, Suite 201 Waltham, MA 02453 July 17, 2017 VIA EDGAR Securities and Exchange Commission Division of Corporation Finance 100 F Street, NE Washington, DC 20549 Re: Kala Pharmaceuticals, Inc. Registration Statement on Form S-1 File No. 333-218936 Request for Acceleration Ladies and Gentlemen: Pursuant to Rule 461 promulgated under the Securities Act of 1933, as amended, Kala Pharmaceuticals, Inc. (the “Registrant”) hereby requests acceleration of the effective date of its Registration Statement on Form S-1 (File No. 333-218936), as amended (the “Registration Statement”), so that it may become effective at 4:00 p.m. Eastern time on July 19, 2017, or as soon thereafter as practicable. [The remainder of this page is intentionally left blank.] Very truly yours, Kala Pharmaceuticals, Inc. By: /s/ Mark Iwicki Name: Mark Iwicki Title: Chief Executive Officer [Signature Page to Request for Acceleration]